S051 Vascular Anomalies Symposium: Classification, Clinical Challenges, and Management Update
DESCRIPTION
Dermatologists play a primary role in diagnosing and directing the management of vascular anomalies. Over the last decade there have been significant developments in the understanding of the pathogenesis of vascular anomalies which have impacted clinical practice, In this session, experts in the field will discuss key topics and literature relating to the evaluation and management of problematic infantile hemangiomas, capillary malformations and vascular anomalies.
LEARNING OBJECTIVES
Examine published data from last year on management of infantile hemangiomas and vascular anomalies
Develop tools for laser therapy and medical management of infantile hemangiomas and vascular anomalies
Enhance knowledge of diagnostic criteria and imaging of high risk infantile hemangiomas and vascular anomalies.
SCHEDULE
1:00 PM
Introduction
Dawn H. Siegel, MD, FAAD
1:05 PM
Infantile Hemangiomas in Preterm Infants
Ilona J. Frieden, MD, FAAD
1:25 PM
Hemangioma Hot Spots
Anita N Haggstrom, MD, FAAD
1:45 PM
Breaking News in PHACE and LUMBAR
Dawn H. Siegel, MD, FAAD, Denise W Metry, MD, FAAD
2:05 PM
Hot Topics in Hemangiomas
Sheilagh M. Maguiness, MD, FAAD
2:25 PM
Advances in medical therapies for vascular anomalies
Beth Ann Drolet, MD, FAAD
2:45 PM
Imaging guidelines for CM-AVM and Sturge-Weber
Eulalia Baselga Torres, MD, IFAAD
3:05 PM
Laser therapy for vascular anomalies
Erin F. Mathes, MD, FAAD
3:25 PM
Journals A Year in Review- JOVA and Beyond
Maria Cecilia Garzon, MD, FAAD
3:45 PM
Challenging cases panel discussion
DIRECTOR
Dawn H. Siegel, MD, FAAD
SPEAKERS
Eulalia Baselga Torres, MD, IFAAD
Beth Ann Drolet, MD, FAAD
Ilona J. Frieden, MD, FAAD
Maria Cecilia Garzon, MD, FAAD
Anita N Haggstrom, MD, FAAD
Sheilagh M. Maguiness, MD, FAAD
Erin F. Mathes, MD, FAAD
Denise W Metry, MD, FAAD
HANDOUTS
DISCLOSURES
Eulalia Baselga Torres, MD, IFAAD
AbbVie – Investigator(Fees); Almirall – Speaker(Honoraria); Cytovation – Consultant(Fees); Demira – Investigator(Fees); Ferrer – Consultant(Honoraria), Speaker(Fees); Isdin – Speaker/Faculty Education(Honoraria); Martiderm – Speaker(Fees); Novartis – Other(Other Financial Benefit), Speaker(Fees); Pierre Fabre Dermatologie – Investigator(Honoraria), Speaker(Fees); Sanofi/Regeneron – Consultant(Fees); venthera – Founder(Stock Options);
Beth Ann Drolet, MD, FAAD
Arkayli Biosciences – Founder(Stock);
Ilona J. Frieden, MD, FAAD
Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Palvella Therapeutics – Consultant (1099 relationship)(Honoraria); Pierre Fabre Dermatologie – Consultant (1099 relationship)(Honoraria);
Maria Cecilia Garzon, MD, FAAD
No financial relationships exist with ineligible companies.
Anita N Haggstrom, MD, FAAD
Palvella Therapeutics – Consultant (1099 relationship)(Fees);
Sheilagh M. Maguiness, MD, FAAD
DYPER – Other(Fees); Galderma – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Stryke Club LLC – Founder(No Compensation Received);
Erin F. Mathes, MD, FAAD
Novartis – Consultant (1099 relationship)(Fees);
Denise W Metry, MD, FAAD
UpToDate – Other(Other Financial Benefit);
Dawn H. Siegel, MD, FAAD
No financial relationships exist with ineligible companies.